Prostate cancer is a serious disease that affects many men. Doctors often look for specific markers to understand how the cancer grows. One marker is called HER2. This review looked at 1,258 cases of prostate cancer to see how often HER2 appears. The findings might change how doctors think about this disease.
The study found that 42 percent of cases showed some level of HER2 activity. However, only 4.9 percent of cases had high levels of this marker. Most patients did not have the high levels that usually require special treatment.
The data showed that patients with more aggressive cancer, known as a higher Gleason score, were more likely to have high HER2 levels. Those with advanced disease stages also showed this pattern. Interestingly, age and PSA levels did not predict high HER2 levels.
This analysis combined data from many sources, which can sometimes make results less clear. The researchers noted that the quality of the original studies varied. They also saw signs that some studies might not have been published because they showed no results. These factors mean we must be careful about how much we trust the numbers.
